The ASCVD Risk Estimator is published jointly by the American College of Cardiology (ACC) and the American Heart Association (AHA) to help health care providers and patients estimate 10-year and lifetime risks for atherosclerotic cardiovascular disease (ASCVD) using the Pooled Cohort Equations and lifetime risk prediction tools. This app is intended as a companion tool to the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk and the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
The ASCVD Risk Estimator provides easy access to recommendations specific to calculated risk estimates. Additionally, the app includes readily accessible guideline reference information for both providers and patients related to therapy, monitoring, and lifestyle. Find out more >>>
New! The BridgeAnticoag app supports clinicians across specialties in safely managing anticoagulation around an invasive procedure for NVAF patients. The app calculates patient and procedural risk to provide individualized advice that balances bleed and stroke risk.
Use the app to assess whether and how to:
Interrupt anticoagulation
Bridge anticoagulation
Restart anticoagulation
Email yourself a detailed report of the app assessment.
The BridgeAnticoag app is available on the web, and all Apple and Android phones and tablets." Find out more >>>
This app is designed to enhance the clinician/patient relationship at the point of care. By using the app's high resolution cardiac graphics and animations, physicians can effectively review and discuss common heart problems and treatment options with their patients. This app is available for download on iPad2, the new iPad, or iOS version 5.0 or higher.
The ACC CathPCI Bleeding Risk Calculator App helps clinicians assess the individualized patient risk of experiencing a bleeding event associated with a PCI procedure. Clinicians can compare individual patient risk to the national average based on data from the CathPCI Registry®. The App facilitates consistent risk assessment and communication between a clinician and patient about the overall PCI procedure. Find out more >>>
The ACC DAPT Risk Calculator App provides decision support for clinicians evaluating the continuation of DAPT therapy for patients at least 12 months post-PCI procedure, and the risk/benefit of continuing or discontinuing DAPT. The App provides a DAPT Risk Score as a numerical value between -2 and +9, where higher DAPT scores suggest that the benefit/risk ratio with prolonged DAPT may be favorable. Conversely, lower DAPT scores suggest that the benefit/risk ratio with prolonged DAPT is NOT favorable. It also calculates the percentage of risk for three end points: myocardial infarction (MI), stent thrombosis, major adverse cardiovascular and cerebrovascular events (MACCE), and bleeding.
The FOCUS App is a decision support tool for clinicians that helps guide and improve appropriate ordering of cardiovascular imaging and tests. The app provides official ACC Appropriate Use Criteria (AUC) ratings and decision algorithms for SPECT MPI, PET, stress echo and CTA to drive clinical decision making for your patient. It automatically calculates risk and pretest probability based on the patient's age, gender and clinical risk factors to derive accurate AUC ratings. The app is currently available for use on iPad.
The ACC's Guideline Clinical App is the mobile home of clinical guideline content and tools for clinicians caring for patients with cardiovascular disease. You can access guideline recommendations, "10 Points" summaries, and tools such as risk scores, calculators and algorithms. Customize your App by using the bookmark, note-taking, and shareable PDF features. Find out more >>>
The ICD/CRT Appropriate Use Criteria App provides decision and documentation support for clinicians assessing the suitability of ICD implantation and CRT. After selecting ICD or CRT as the intended therapy, clinicians will enter a patient’s LVEF and NYHA class to:
Obtain an appropriate use rating for ICD/CRT
View the likelihood of CMS coverage for the patient receiving an ICD
Produce a summary of patient inputs and advice for email.
LDL-C Manager helps clinicians reduce ASCVD risk by managing LDL-C. The app guides clinicians through one continuous lipid-lowering process by linking the ASCVD Risk Estimator, Statin Intolerance app, and the brand new Lipid-Lowering Therapy tool based on the 2016 Role of Non-Statin Therapies Expert Consensus Decision Pathway.
Input individualized patient data to:
Estimate ASCVD risk
Review customized lifestyle and statin initiation advice
Assess patient-specific response to lipid-lowering therapy
Determine when and which non-statin therapies should be considered
Email yourself a detailed report of all assessments conducted within the app.
The NCDR Clinical Quality Coach™ provides physicians with a convenient mobile solution for documenting and tracking their clinical practice improvement activities. Leveraging National Cardiovascular Data Registry data, physicians are able to access and track quality performance metrics and use their data to inform quality improvement efforts. Currently available for physicians participating in the CathPCI Registry® – other NCDR registries will be added soon. The NCDR Clinical Quality Coach also provides physicians with an easy and streamlined way to submit documentation of their clinical practice improvement activities for American Board of Medical Specialties (ABMS) credit.
The ACC Statin Intolerance App guides clinicians through the process of managing and treating patients who report muscle symptoms while on statin therapy. Clinicians can use the app to evaluate possible intolerance to a patient’s current statin prescription, follow steps to manage and treat a patient who reports muscle symptoms on a statin, and compare statin characteristics and drug interactions to inform management of LDL-related risk. Information in the app is derived from ACC/AHA cholesterol guidelines and best practices. Find out more >>>
The STS/ACC TAVR In-Hospital Mortality Risk App assists clinicians in determining the predicted in-hospital mortality risk of a patient who is considering TAVR as a treatment option for AVR. Clinicians can evaluate a patient’s mortality risk and compare it to the national average based on STS/ACC TVT Registry data.Find out more >>>
Subscribers to ACCEL can search for and retrieve interviews from the popular audio journal online. This area features MP3 files that are easily searchable and downloadable to your computer and MP3 player.
The latest research and clinical practice updates in cardiology are at your fingertips with the JACC Journals app. Now you can read the entire family of journals from the ACC in a single app, across all IOS and Android devices. You can: browse new issues; jump to featured articles; interact with figures, tables and multimedia content; personalize your experience with My Reading List; save articles for offline reading; share articles via social media; email useful content; and much more!
ACC members can engage with lawmakers and influence health policy with the ACC Advocacy Action mobile app. The app includes an interactive congressional directory to locate lawmakers, timely talking points to share during congressional visits, an event scheduler to keep track of Capitol Hill meetings, social media tools to engage with legislators, and more.
Available exclusively to ACC members, ACC Connect delivers a convenient mobile application with several modules to help members connect, as well as interact and engage with their colleagues, peers and the College. ACC Connect also allows members to search the member directory and update their profile and get the latest ACC news. Compatible with iPhone, iPod Touch, and iPad. Requires iOS 3.0 or later.
NEW | Share Your Interests by Joining One of ACC.org's Member Sections
ACC.orgMember Sections are the perfect place to meet, network and share information with fellow ACC members.
Log in to MyACC
